View ValuationMicro-X 将来の成長Future 基準チェック /66Micro-X利益と収益がそれぞれ年間105.5%と34.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に23.2% 106.5%なると予測されています。主要情報105.5%収益成長率106.46%EPS成長率Medical Equipment 収益成長16.1%収益成長率34.9%将来の株主資本利益率23.23%アナリストカバレッジLow最終更新日04 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Dec 18Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.18 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.18 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 18,750,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 18,750,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 37,250,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,500,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Transaction Features: Subsequent Direct Listingお知らせ • Nov 27Micro-X Limited Unveils Updated Rover Mobile X-Ray System Ahead of International Debut At RSNA 2025Micro-X Limited will debut its updated Rover mobile X-ray system at the Radiological Society of North America (RSNA) Annual Meeting in Chicago this November. The launch marks the international launch of the next-generation platform, engineered to deliver improved workflow, imaging performance, and ease of use. The updated Micro-X Rover mobile digital radiography X-ray device is designed to improve workflow, with high-quality diagnostic imaging and ease of use. The new Rover evolves Micro-X's proven lightweight, motor-free design, with enhancements including the latest Lumen glass-free high-resolution detector, in-bin charging for improved readiness, a larger high-definition touchscreen interface, improved serviceability, and a more compact stowage footprint for use in constrained clinical environments. Together, these upgrades strengthen the Rover's role in fast, accurate, point-of-care digital radiography. Using Micro-X's proprietary Nano Electronic X-ray Technology, the Rover delivers high-quality digital radiography with exceptional maneuverability, gentle navigation across hospital floors and lifts, and minimal maintenance requirements. The new in-bin charging solution removes the need for external cabling and reduces downtime, ensuring the Rover remains ready when clinicians need it most.お知らせ • Oct 10Micro-X Limited, Annual General Meeting, Nov 11, 2025Micro-X Limited, Annual General Meeting, Nov 11, 2025.お知らせ • Feb 06Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.08604 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.08604 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 58,371,999 Price\Range: AUD 0.07 Discount Per Security: AUD 0.0042 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 24,285,714 Price\Range: AUD 0.07 Discount Per Security: AUD 0.0042 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 4,285,714 Price\Range: AUD 0.07 Discount Per Security: AUD 0.0042 Transaction Features: Rights Offering; Subsequent Direct Listingお知らせ • Oct 11Micro-X Limited, Annual General Meeting, Nov 12, 2024Micro-X Limited, Annual General Meeting, Nov 12, 2024. Location: a14 6 mab eastern promenade, tonsley, south australia 5042, Australiaお知らせ • Apr 24Micro-X Limited has completed a Follow-on Equity Offering in the amount of AUD 3.9 million.Micro-X Limited has completed a Follow-on Equity Offering in the amount of AUD 3.9 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,052,631 Price\Range: AUD 0.095 Discount Per Security: AUD 0.0057 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Apr 19Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,526,316 Price\Range: AUD 0.095 Discount Per Security: AUD 0.0057 Security Features: Attached Optionsお知らせ • Apr 18Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 42,105,263 Price\Range: AUD 0.095 Discount Per Security: AUD 0.0057 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Mar 12Micro-X Reveals First Look At New Mobile Stroke Diagnosis DeviceA virtual reality walkthrough of mobile stroke diagnosis technology has been released by x-ray innovator Micro-X. The VR shows how the Head CT Scanner is designed to be used in an ambulance, bringing mobile stroke diagnosis to the patient to reduce the time to treatment. Stored in the side of an ambulance, the Head CT can be easily opened and operated, and if built successfully, will send images to stroke clinicians for diagnosis. The medical device is currently under development and due to commence human clinical trials late this year. When completed, the Micro-X Head CT will be less than 70kg and will contain 21 mini x-ray tubes, as opposed to a conventional CT that is more than 1200kg with one x-ray tube in a rotating gantry. Micro-X's patented Nano Electronic X-ray Technology uses carbon nanotubes to miniaturise x-ray tubes. Mobile stroke units - fully equipped, custom-built specialist vehicles that accommodate a modified, but still very heavy CT scanner at more than 500 kg, and specialist acute stroke personnel - are being introduced around Australia. The equipment and required staffing are a high cost, with the custom-built ambulance also requiring reinforcement to support the weight of the CT scanner. The good patient outcomes from these units provides support for a truly mobile solution that is lower cost and more widely deployable. The development of Micro-X's world-first mobile stroke technology is funded through $8 million of a $40 million grant awarded to the Australian Stroke Alliance under the Australian Government's Medical Research Future Fund.お知らせ • Oct 16Micro-X Limited, Annual General Meeting, Nov 16, 2023Micro-X Limited, Annual General Meeting, Nov 16, 2023, at 13:30 AUS Eastern Standard Time. Location: A14 6 MAB Eastern Promenade, Tonsley South Australia Australia Agenda: To receive and consider the financial report of the Company and the related reports of the Directors (including the Remuneration Report) and the Auditor, for the year ended 30 June 2023; to consider the Remuneration Report; to re-elect the Director of the Company; to approve the issue of Shares to Mr David Knox in Lieu of Cash Payments for Directors' Fees; and to consider other matters.業績と収益の成長予測OTCPK:MCRX.F - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数6/30/2028466N/A516/30/202729-1N/A016/30/202627-7N/AN/A112/31/202517-12-10-10N/A9/30/202515-13-9-9N/A6/30/202513-14-9-9N/A3/31/202514-12-9-9N/A12/31/202414-11-9-9N/A9/30/202415-10-8-8N/A6/30/202415-10-7-6N/A3/31/202415-12-6-6N/A12/31/202315-15-5-5N/A9/30/202315-13-9-8N/A6/30/202315-11-12-11N/A3/31/202315-11-14-13N/A12/31/202215-12-15-14N/A9/30/202212-15-17-16N/A6/30/20229-17-19-18N/A3/31/20226-18-18-16N/A12/31/20214-19-16-15N/A9/30/20214-17-13-12N/A6/30/20214-15-11-10N/A3/31/20215-13-12-11N/A12/31/20206-11-13-12N/A9/30/20205-10-12-11N/A6/30/20204-10-12-9N/A3/31/20203-9-11-8N/A12/31/20192-8-10-7N/A9/30/20192-9N/A-7N/A6/30/20192-10N/A-7N/A3/31/20192-14N/A-8N/A12/31/20182-18N/A-9N/A9/30/20182-17N/A-8N/A6/30/20182-17N/A-8N/A3/31/20181-14N/A-9N/A12/31/20171-11N/A-11N/A9/30/20171-12N/A-11N/A6/30/20171-13N/A-11N/A3/31/20171-13N/A-10N/A12/31/20161-13N/A-9N/A9/30/20161-12N/A-11N/A6/30/20161-11N/A-13N/A3/31/20161-12N/A-10N/A12/31/20150-13N/A-8N/A9/30/20150-11N/A-7N/A6/30/20150-10N/A-6N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MCRX.Fは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 3.5% ) よりも高い成長率であると考えられます。収益対市場: MCRX.F今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: MCRX.F今後 3 年以内に収益を上げることが予想されます。収益対市場: MCRX.Fの収益 ( 34.9% ) US市場 ( 11.7% ) よりも速いペースで成長すると予測されています。高い収益成長: MCRX.Fの収益 ( 34.9% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MCRX.Fの 自己資本利益率 は、3年後には高くなると予測されています ( 23.2 %)成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 21:18終値2026/05/06 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Micro-X Limited 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Scott PowerCGS InternationalScott PowerMorgans Financial Limited
お知らせ • Dec 18Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.18 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.18 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 18,750,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 18,750,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 37,250,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,500,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Transaction Features: Subsequent Direct Listing
お知らせ • Nov 27Micro-X Limited Unveils Updated Rover Mobile X-Ray System Ahead of International Debut At RSNA 2025Micro-X Limited will debut its updated Rover mobile X-ray system at the Radiological Society of North America (RSNA) Annual Meeting in Chicago this November. The launch marks the international launch of the next-generation platform, engineered to deliver improved workflow, imaging performance, and ease of use. The updated Micro-X Rover mobile digital radiography X-ray device is designed to improve workflow, with high-quality diagnostic imaging and ease of use. The new Rover evolves Micro-X's proven lightweight, motor-free design, with enhancements including the latest Lumen glass-free high-resolution detector, in-bin charging for improved readiness, a larger high-definition touchscreen interface, improved serviceability, and a more compact stowage footprint for use in constrained clinical environments. Together, these upgrades strengthen the Rover's role in fast, accurate, point-of-care digital radiography. Using Micro-X's proprietary Nano Electronic X-ray Technology, the Rover delivers high-quality digital radiography with exceptional maneuverability, gentle navigation across hospital floors and lifts, and minimal maintenance requirements. The new in-bin charging solution removes the need for external cabling and reduces downtime, ensuring the Rover remains ready when clinicians need it most.
お知らせ • Oct 10Micro-X Limited, Annual General Meeting, Nov 11, 2025Micro-X Limited, Annual General Meeting, Nov 11, 2025.
お知らせ • Feb 06Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.08604 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 6.08604 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 58,371,999 Price\Range: AUD 0.07 Discount Per Security: AUD 0.0042 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 24,285,714 Price\Range: AUD 0.07 Discount Per Security: AUD 0.0042 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 4,285,714 Price\Range: AUD 0.07 Discount Per Security: AUD 0.0042 Transaction Features: Rights Offering; Subsequent Direct Listing
お知らせ • Oct 11Micro-X Limited, Annual General Meeting, Nov 12, 2024Micro-X Limited, Annual General Meeting, Nov 12, 2024. Location: a14 6 mab eastern promenade, tonsley, south australia 5042, Australia
お知らせ • Apr 24Micro-X Limited has completed a Follow-on Equity Offering in the amount of AUD 3.9 million.Micro-X Limited has completed a Follow-on Equity Offering in the amount of AUD 3.9 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,052,631 Price\Range: AUD 0.095 Discount Per Security: AUD 0.0057 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Apr 19Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,526,316 Price\Range: AUD 0.095 Discount Per Security: AUD 0.0057 Security Features: Attached Options
お知らせ • Apr 18Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million.Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 42,105,263 Price\Range: AUD 0.095 Discount Per Security: AUD 0.0057 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Mar 12Micro-X Reveals First Look At New Mobile Stroke Diagnosis DeviceA virtual reality walkthrough of mobile stroke diagnosis technology has been released by x-ray innovator Micro-X. The VR shows how the Head CT Scanner is designed to be used in an ambulance, bringing mobile stroke diagnosis to the patient to reduce the time to treatment. Stored in the side of an ambulance, the Head CT can be easily opened and operated, and if built successfully, will send images to stroke clinicians for diagnosis. The medical device is currently under development and due to commence human clinical trials late this year. When completed, the Micro-X Head CT will be less than 70kg and will contain 21 mini x-ray tubes, as opposed to a conventional CT that is more than 1200kg with one x-ray tube in a rotating gantry. Micro-X's patented Nano Electronic X-ray Technology uses carbon nanotubes to miniaturise x-ray tubes. Mobile stroke units - fully equipped, custom-built specialist vehicles that accommodate a modified, but still very heavy CT scanner at more than 500 kg, and specialist acute stroke personnel - are being introduced around Australia. The equipment and required staffing are a high cost, with the custom-built ambulance also requiring reinforcement to support the weight of the CT scanner. The good patient outcomes from these units provides support for a truly mobile solution that is lower cost and more widely deployable. The development of Micro-X's world-first mobile stroke technology is funded through $8 million of a $40 million grant awarded to the Australian Stroke Alliance under the Australian Government's Medical Research Future Fund.
お知らせ • Oct 16Micro-X Limited, Annual General Meeting, Nov 16, 2023Micro-X Limited, Annual General Meeting, Nov 16, 2023, at 13:30 AUS Eastern Standard Time. Location: A14 6 MAB Eastern Promenade, Tonsley South Australia Australia Agenda: To receive and consider the financial report of the Company and the related reports of the Directors (including the Remuneration Report) and the Auditor, for the year ended 30 June 2023; to consider the Remuneration Report; to re-elect the Director of the Company; to approve the issue of Shares to Mr David Knox in Lieu of Cash Payments for Directors' Fees; and to consider other matters.